# Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx

> **NCT03986671** · NA · COMPLETED · sponsor: **Powell Mansfield Inc.** · enrollment: 50 (actual)

## Conditions studied

- Obstructive Sleep Apnea
- Amyotrophic Lateral Sclerosis
- Muscular Dystrophies
- Healthy

## Interventions

- **DEVICE:** Transmembrane EMG Oropharynx Probe

## Key facts

- **NCT ID:** NCT03986671
- **Lead sponsor:** Powell Mansfield Inc.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-30
- **Primary completion:** 2021-03-26
- **Final completion:** 2021-03-26
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03986671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03986671, "Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03986671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*